FDA Approps Amendment Targets Chief Counsel Troy; Pfizer Ties Challenged
This article was originally published in The Pink Sheet Daily
Executive Summary
Amendment by Rep. Hinchey moves $500,000 from Chief Counsel's office to CDER's ad division. Troy wasted taxpayer money and undermined FDA's mission by intervening in state civil cases against drug and device manufacturers, Hinchey asserts.